ArticleUrology case reports2026
Surgical, endovascular, and systemic management of renal cell carcinoma with intravascular recurrence.
Article in Urology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal cell carcinoma (RCC) recurrence within the vasculature represents a rare and challenging clinical scenario with limited evidence to guide management. We report a patient with clear cell RCC and level 4 IVC thrombus who underwent successful radical nephrectomy with IVC thrombectomy and subsequently developed disease recurrence in the supradiaphragmatic IVC and pulmonary arteries. Multidisciplinary management included novel endovascular removal of the recurrent IVC tumor followed by pulmonary bilobectomy for progressive tumor emboli. The patient remains without evidence of recurrent disease. This case highlights the complex multidisciplinary decision-making and potential role of minimally invasive endovascular techniques in managing intravascular RCC.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.